{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:39Z","timestamp":1707523959686},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,30]]},"DOI":"10.7759\/cureus.44378","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T13:18:29Z","timestamp":1693401509000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidental Normocalcemic Primary Hyperparathyroidism Presenting With Symptomatic Hypophosphatemia: A Case Report"],"prefix":"10.7759","author":[{"given":"Omar","family":"Tabbikha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Chamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"El Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01422.x","article-title":"Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features","volume":"257","author":"Bilezikian JP","year":"2005","unstructured":"Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med. 2005, 257:6-17. 10.1111\/j.1365-2796.2004.01422.x","journal-title":"J Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27302006000400011","article-title":"From mild to severe primary hyperparathyroidism: the Brazilian experience","volume":"50","author":"Bandeira F","year":"2006","unstructured":"Bandeira F, Griz L, Caldas G, Bandeira C, Freese E. From mild to severe primary hyperparathyroidism: the Brazilian experience. Arq Bras Endocrinol Metabol. 2006, 50:657-63. 10.1590\/s0004-27302006000400011","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.1061","article-title":"Normocalcemic primary hyperparathyroidism: need for a standardized clinical approach","volume":"36","author":"Zavatta G","year":"2021","unstructured":"Zavatta G, Clarke BL. Normocalcemic primary hyperparathyroidism: need for a standardized clinical approach. Endocrinol Metab (Seoul). 2021, 36:525-35. 10.3803\/EnM.2021.1061","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic primary hyperparathyroidism","volume":"16","author":"Cusano NE","year":"2013","unstructured":"Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom. 2013, 16:33-9. 10.1016\/j.jocd.2012.12.001","journal-title":"J Clin Densitom"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.026948","article-title":"Circulating forms of parathyroid hormone: peeling back the onion","volume":"49","author":"Bringhurst FR","year":"2003","unstructured":"Bringhurst FR. Circulating forms of parathyroid hormone: peeling back the onion. Clin Chem. 2003, 49:1973-5. 10.1373\/clinchem.2003.026948","journal-title":"Clin Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg SJ","year":"2014","unstructured":"Silverberg SJ, Clarke BL, Peacock M, et al.. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014, 99:3580-94. 10.1210\/jc.2014-1415","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10391","article-title":"Normocalcemic hyperparathyroidism: a heterogeneous disorder often misdiagnosed?","volume":"4","author":"Zavatta G","year":"2020","unstructured":"Zavatta G, Clarke BL. Normocalcemic hyperparathyroidism: a heterogeneous disorder often misdiagnosed?. JBMR Plus. 2020, 4:e10391. 10.1002\/jbm4.10391","journal-title":"JBMR Plus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa084","article-title":"Normocalcemic hyperparathyroidism: study of its prevalence and natural history","volume":"105","author":"Schini M","year":"2020","unstructured":"Schini M, Jacques RM, Oakes E, Peel NF, Walsh JS, Eastell R. Normocalcemic hyperparathyroidism: study of its prevalence and natural history. J Clin Endocrinol Metab. 2020, 105:e1171-86. 10.1210\/clinem\/dgaa084","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2015.03.005","article-title":"How to manage an isolated elevated PTH?","volume":"76","author":"Souberbielle JC","year":"2015","unstructured":"Souberbielle JC, Cavalier E, Cormier C. How to manage an isolated elevated PTH?. Ann Endocrinol (Paris). 2015, 76:134-41. 10.1016\/j.ando.2015.03.005","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0487-8","article-title":"New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study","volume":"20","author":"Guo Y","year":"2020","unstructured":"Guo Y, Wang Q, Lu C, Fan P, Li J, Luo X, Chen D. New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study. BMC Endocr Disord. 2020, 20:5. 10.1186\/s12902-019-0487-8","journal-title":"BMC Endocr Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.11005\/jbm.2014.21.3.217","article-title":"Increase in the serum parathyroid hormone level during a bisphosphonate drug holiday","volume":"21","author":"Song YK","year":"2014","unstructured":"Song YK, Kim JM, Park SJ, Lee SK. Increase in the serum parathyroid hormone level during a bisphosphonate drug holiday. J Bone Metab. 2014, 21:217-22. 10.11005\/jbm.2014.21.3.217","journal-title":"J Bone Metab"},{"key":"ref12","article-title":"Physiology, phosphate","author":"Qadeer HA","year":"2022","unstructured":"Qadeer HA, Bashir K. Physiology, phosphate. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/bdrc.20136","article-title":"Phosphate: known and potential roles during development and regeneration of teeth and supporting structures","volume":"84","author":"Foster BL","year":"2008","unstructured":"Foster BL, Tompkins KA, Rutherford RB, Zhang H, Chu EY, Fong H, Somerman MJ. Phosphate: known and potential roles during development and regeneration of teeth and supporting structures. Birth Defects Res C Embryo Today. 2008, 84:281-314. 10.1002\/bdrc.20136","journal-title":"Birth Defects Res C Embryo Today"},{"key":"ref14","article-title":"Hypophosphatemia","author":"Sharma S","year":"2022","unstructured":"Sharma S, Hashmi MF, Castro D. Hypophosphatemia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq039","article-title":"Medication-induced hypophosphatemia: a review","volume":"103","author":"Liamis G","year":"2010","unstructured":"Liamis G, Milionis HJ, Elisaf M. Medication-induced hypophosphatemia: a review. QJM. 2010, 103:449-59. 10.1093\/qjmed\/hcq039","journal-title":"QJM"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian JP","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014, 99:3561-9. 10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6998-0","article-title":"Biochemical and skeletal outcomes of parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism","volume":"26","author":"Sho S","year":"2019","unstructured":"Sho S, Kuo EJ, Chen AC, Li N, Yeh MW, Livhits MJ. Biochemical and skeletal outcomes of parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism. Ann Surg Oncol. 2019, 26:539-46. 10.1245\/s10434-018-6998-0","journal-title":"Ann Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-018-1659-0","article-title":"Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?","volume":"403","author":"Traini E","year":"2018","unstructured":"Traini E, Bellantone R, Tempera SE, Russo S, De Crea C, Lombardi CP, Raffaelli M. Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?. Langenbecks Arch Surg. 2018, 403:317-23. 10.1007\/s00423-018-1659-0","journal-title":"Langenbecks Arch Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2019.06.043","article-title":"Normocalcemic hyperparathyroidism: a collaborative endocrine surgery quality improvement program analysis","volume":"167","author":"Pandian TK","year":"2020","unstructured":"Pandian TK, Lubitz CC, Bird SH, Kuo LE, Stephen AE. Normocalcemic hyperparathyroidism: a collaborative endocrine surgery quality improvement program analysis. Surgery. 2020, 167:168-72. 10.1016\/j.surg.2019.06.043","journal-title":"Surgery"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0194599818793879","article-title":"Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome","volume":"159","author":"Trinh G","year":"2018","unstructured":"Trinh G, Rettig E, Noureldine SI, et al.. Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome. Otolaryngol Head Neck Surg. 2018, 159:630-7. 10.1177\/0194599818793879","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/174730-incidental-normocalcemic-primary-hyperparathyroidism-presenting-with-symptomatic-hypophosphatemia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:05Z","timestamp":1707508385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/174730-incidental-normocalcemic-primary-hyperparathyroidism-presenting-with-symptomatic-hypophosphatemia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.44378","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,30]]}}}